Abstract
Abdominal aortic aneurysm (AAA) is a devastating disease associated with high prevalence of death due to aortic rupture. Currently the therapy is restricted to surgical procedures to prevent aortic rupture, which in turn has a risk for postoperative mortality. There are no proven pharmacological therapies available to prevent expansion or rupture of AAA due to the paucity of knowledge on the mechanisms underlying the nature and pathophysiological processes of this complex disease. Animal models are powerful tools to provide mechanistic insights into understanding the development of AAA. Numerous pharmacological approaches have been explored as potential therapies in experimental AAA in the past decade. This review overviews recent advances in mechanistic studies of AAA in angiotensin II-infused mouse models and highlights their clinical relevance for possible therapeutic targets.
Keywords: Abdominal aortic aneurysms, mechanisms, angiotensin, inflammation, mouse.
Current Pharmaceutical Design
Title:Angiotensin II and Abdominal Aortic Aneurysms: An update
Volume: 21 Issue: 28
Author(s): Jing Liu, Alan Daugherty and Hong Lu
Affiliation:
Keywords: Abdominal aortic aneurysms, mechanisms, angiotensin, inflammation, mouse.
Abstract: Abdominal aortic aneurysm (AAA) is a devastating disease associated with high prevalence of death due to aortic rupture. Currently the therapy is restricted to surgical procedures to prevent aortic rupture, which in turn has a risk for postoperative mortality. There are no proven pharmacological therapies available to prevent expansion or rupture of AAA due to the paucity of knowledge on the mechanisms underlying the nature and pathophysiological processes of this complex disease. Animal models are powerful tools to provide mechanistic insights into understanding the development of AAA. Numerous pharmacological approaches have been explored as potential therapies in experimental AAA in the past decade. This review overviews recent advances in mechanistic studies of AAA in angiotensin II-infused mouse models and highlights their clinical relevance for possible therapeutic targets.
Export Options
About this article
Cite this article as:
Liu Jing, Daugherty Alan and Lu Hong, Angiotensin II and Abdominal Aortic Aneurysms: An update , Current Pharmaceutical Design 2015; 21 (28) . https://dx.doi.org/10.2174/1381612821666150826093318
DOI https://dx.doi.org/10.2174/1381612821666150826093318 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Review of Macrolide Treatment of Atherosclerosis and Abdominal Aortic Aneurysms
Current Drug Targets - Infectious Disorders CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke
Current Pharmaceutical Design Eye Disorders in Diabetes: Potential Drug Targets
Infectious Disorders - Drug Targets Cyclooxygenase-2 and Prostaglandin E2 are Associated with Middle Cerebral Artery Occlusion and Hemorrhage in Patients with Moyamoya Disease
Current Neurovascular Research Blood-Brain-Barrier Models for the Investigation of Transporter- and Receptor-Mediated Amyloid-β Clearance in Alzheimers Disease
Current Alzheimer Research Transseptal Access to the Left Atrium: Tips and Tricks to Keep it Safe Derived from Single Operator Experience and Review of the Literature
Current Cardiology Reviews Significant Association of CXCL12 rs1746048 with LDL-C Level in Intracranial Aneurysms
Current Neurovascular Research Randomized Clinical Stroke Trials in 2006
Current Vascular Pharmacology Review of Some Recent Patents on the Large-Eddy Simulation Technique in Turbulence
Recent Patents on Mechanical Engineering Pathophysiology of Cardiovascular Diseases and the Role of Vitamins, and Herbal Extracts in the Reduction of Cardiovascular Risks
Cardiovascular & Hematological Agents in Medicinal Chemistry Role of Alpha-1 Antitrypsin (AAT) in Ocular Allergy and Uveitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Beneficial Extracardiac Effects of Cardiovascular Medications
Current Cardiology Reviews Progress in the Development of Matrix Metalloproteinase Inhibitors
Current Medicinal Chemistry Amino Acid Metabolic Routes in Trypanosoma cruzi: Possible Therapeutic Targets Against Chagas; Disease
Current Drug Targets - Infectious Disorders Hypertension - Current Natural Strategies to Lower Blood Pressure
Current Pharmaceutical Design Hypertensive Left Ventricular Hypertrophy Regression: Does It Matter?
Current Hypertension Reviews Untargeted Metabolomics Provides Insight into the Mechanisms Underlying Resistant Hypertension
Current Medicinal Chemistry Re-Wiring the Circuit: Mitochondria as a Pharmacological Target in Liver Disease
Current Medicinal Chemistry Development of Anti-Atherosclerosis Therapy Based on the Inflammatory and Proliferative Aspects of the Disease
Current Pharmaceutical Design Assessment of Vascular Geometry for Bilateral Carotid Artery Ligation to Induce Early Basilar Terminus Aneurysmal Remodeling in Rats
Current Neurovascular Research